If you’re a water resources student in Amarillo, you know the struggle: Texas watersheds often have incomplete streamflow ...

Starting December 16, 2025, Meta will begin adding AI chats to the behavioral data it gathers to further personalize its experiences and ad targeting. This move blurs the line between private ...

Greetings, and welcome to the Erasca Corporate Update Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jonathan Lim, CEO and Chairman.

REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

Seventeen wagons set up in Abilene to compete in this year's Texas Heritage Classic Chuckwagon Cook-off at the Taylor County Expo Center. Repeat Child Sex Offender Arrested Again in Tom Green County, ...

Oak Point, in Denton County, is hosting a special election on May 2. In the special election, voters will decide whether to reapprove a sales and use tax for road repairs. The reauthorization of the ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

Six poster presentations showcase Zymeworks’ next-generation ADC programs, including multiple first-in-class pan-RAS inhibitor ADCs Data highlight efficacy, tumor-selective delivery, and favorable ...

Los Angeles Mayor Karen Bass rolled out what she billed as a brand-new climate plan Thursday – but much of it turns out to be recycled. The sweeping blueprint is supposed to slash emissions, expand ...

Wisconsin is becoming a popular location for data centers due to its climate, water access, and affordable land. The majority of a data center's water footprint comes from the offsite electricity ...

Earlier this week, Revolution Medicines reported positive results from a global Phase III trial of its RAS‑targeting inhibitor daraxonrasib (RMC-6236) in metastatic pancreatic ductal adenocarcinoma ...